Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Change in Receivables (2016 - 2025)

Biomerica's Change in Receivables history spans 16 years, with the latest figure at -$227000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 0.87% year-over-year to -$227000.0; the TTM value through Nov 2025 reached -$311000.0, down 217.8%, while the annual FY2025 figure was -$209000.0, 197.21% down from the prior year.
  • Change in Receivables for Q4 2025 was -$227000.0 at Biomerica, down from $512000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $708000.0 in Q3 2023 and bottomed at -$777752.0 in Q3 2021.
  • The 5-year median for Change in Receivables is -$16992.5 (2022), against an average of $24077.8.
  • The largest annual shift saw Change in Receivables crashed 4209.87% in 2021 before it skyrocketed 1687.43% in 2023.
  • A 5-year view of Change in Receivables shows it stood at -$361698.0 in 2021, then surged by 115.76% to $57000.0 in 2022, then plummeted by 749.12% to -$370000.0 in 2023, then surged by 38.11% to -$229000.0 in 2024, then rose by 0.87% to -$227000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Change in Receivables are -$227000.0 (Q4 2025), $512000.0 (Q3 2025), and -$536000.0 (Q2 2025).